Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it will host ...

Arteriovenous fistulas of the kidney are rare and are classified as acquired, idiopathic or arising in a congenital arteriovenous malformation. 1 In addition, with the more widespread use of ...

Please provide your email address to receive an email when new articles are posted on . A new, minimally invasive system which uses radiofrequency energy instead of open surgery to create ...

The purpose of this paper is to present an additional case of coexistent acquired and congenital arteriovenous fistulas with associated pseudoaneurysms complicated by endarteritis and endocarditis ...

If you’re living with advanced kidney disease, preparing for dialysis can feel overwhelming. One crucial decision is how your blood will be accessed for treatment. While there are different options, ...

CHICAGO – Closure of arteriovenous fistulas used in dialysis patients improved heart function after transition to successful kidney transplantation, according to a small study reported here. Patients ...

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — In this video exclusive, Tony Das, MD, an interventional cardiologist at Walnut Hill Medical Center, ...

The increased risk for venous thromboembolism with an arteriovenous graft is one factor for clinicians and patients to consider in the choice of vascular access for hemodialysis. Among permanent ...

"Arteriovenous (AV) Fistula Pipeline 2025"DelveInsight's,“Arteriovenous (AV) Fistula – Pipeline Insight, 2025,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in ...

NEWARK, Del, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The global arteriovenous fistula treatment market is projected to amass revenue of about US$ 1,381.1 Mn by 2032, up from US$ 731.6 Mn in 2022, advancing ...